Related Experiment Video
Updated: Mar 23, 2026
12:49
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
3.3K
Lipids in liver transplant recipients
Anna Hüsing1, Iyad Kabar1, Hartmut H Schmidt1
1Anna Hüsing, Iyad Kabar, Hartmut H Schmidt, Department of Transplant Medicine, University Hospital Münster, 48149 Münster, Germany.
World Journal of Gastroenterology
|March 30, 2016
Summary
Hyperlipidemia is common after liver transplantation, affecting up to 71% of patients. Effective management involves lifestyle changes, adjusting immunosuppressants, and cautious use of lipid-lowering drugs to prevent cardiovascular events.
Area of Science:
- Hepatology
- Cardiology
- Pharmacology
Background:
- Hyperlipidemia affects up to 71% of liver transplant recipients.
- Lipid disorders are multifactorial, influenced by immunosuppressants, obesity, and diabetes.
- Cardiovascular event risk is elevated in 64% of liver transplant recipients.
Purpose of the Study:
- To recommend an approach for managing lipid metabolism disorders in liver transplant recipients.
- To highlight the importance of managing dyslipidemia and cardiovascular risk factors post-transplant.
- To address the lack of current guidelines for lipid management in this population.
Main Methods:
- Review of existing literature on hyperlipidemia post-liver transplantation.
- Analysis of factors contributing to lipid disorders in transplant recipients.
- Discussion of treatment strategies including lifestyle modification, immunosuppressant adjustment, and pharmacotherapy.
Main Results:
- Hyperlipidemia is a prevalent complication with multifactorial causes.
- Cardiovascular risk is significantly increased in liver transplant recipients.
- Treatment involves lifestyle changes, immunosuppressant modification, and lipid-lowering agents with careful monitoring for drug interactions.
Conclusions:
- Management of hyperlipidemia is crucial for improving long-term outcomes in liver transplant recipients.
- Careful monitoring for drug-drug interactions and avoiding combination lipid-lowering therapies are essential.
- An evidence-based approach is recommended due to the absence of specific guidelines.
Related Concept Videos
01:28Kidney Transplant I: Introduction
679
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
679
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
793
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
793